Cargando…

Quality of life and metabolic status in mildly depressed patients with type 2 diabetes treated with paroxetine: A double-blind randomised placebo controlled 6-month trial

BACKGROUND: Depression is prevalent in people with type 2 diabetes and affects both glycaemic control and overall quality of life. The aim of this investigator-initiated trial was to evaluate the effect of the antidepressant paroxetine on quality of life, metabolic control, and mental well-being in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paile-Hyvärinen, Maria, Wahlbeck, Kristian, Eriksson, Johan G
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1914073/ https://www.ncbi.nlm.nih.gov/pubmed/17570858 http://dx.doi.org/10.1186/1471-2296-8-34

Ejemplares similares

Quality of life and metabolic status in mildly depressed women with type 2 diabetes treated with paroxetine: A single-blind randomised placebo controlled trial
por: Paile-Hyvärinen, Maria, et al.
Publicado: (2003)

Double-blind, comparative study of milnacipran and paroxetine in Japanese patients with major depression
por: Kamijima, Kunitoshi, et al.
Publicado: (2013)

Suicide attempts in clinical trials with paroxetine randomised against placebo
por: Aursnes, Ivar, et al.
Publicado: (2005)

Double-blind, comparative study of milnacipran and paroxetine in Japanese patients with major depression [Corrigendum]
Publicado: (2013)

Biomarkers for response in major depression: comparing paroxetine and venlafaxine from two randomised placebo-controlled clinical studies
por: Carboni, Lucia, et al.
Publicado: (2019)

Even more suicide attempts in clinical trials with paroxetine randomised against placebo
por: Aursnes, Ivar, et al.
Publicado: (2006)

Multicentre randomised double-blinded placebo-controlled trial of favipiravir in adults with mild COVID-19
por: Bosaeed, Mohammad, et al.
Publicado: (2021)

Comparison of paroxetine and agomelatine in depressed type 2 diabetes mellitus patients: a double-blind, randomized, clinical trial
por: Kang, Ruiying, et al.
Publicado: (2015)

Treatment of major depressive disorders with generic duloxetine and paroxetine: a multi-centered, double-blind, double-dummy, randomized controlled clinical trial
por: WANG, Zhiyang, et al.
Publicado: (2015)

Effectiveness of paroxetine in the treatment of poststroke depression
por: Ma, Chen, et al.
Publicado: (2018)

Efficacy of cognitive behavioral therapy with paroxetine and paroxetine only for social anxiety disorder: A behavioral, placebo-controlled study
por: Samantray, Narendranath, et al.
Publicado: (2019)

The Efficacy and Safety of On-demand Tramadol and Paroxetine Use in Treatment of Life Long Premature Ejaculation: A Randomized Double-blind Placebo-controlled Clinical Trial
por: Hamidi-Madani, Ali, et al.
Publicado: (2018)

Randomised Double-blind Placebo-Controlled Multicentre Trial for the Effects of Yokukansan in Smokers with Depressive Tendencies
por: Komiyama, Maki, et al.
Publicado: (2023)

The Efficacy of Paroxetine and Placebo in Treating Anxiety and Depression: A Meta-Analysis of Change on the Hamilton Rating Scales
por: Sugarman, Michael A., et al.
Publicado: (2014)

Paroxetine in the treatment of recurrent brief depressive disorder
por: Prakash, Sathya, et al.
Publicado: (2013)

Testosterone replacement in young male cancer survivors: A 6-month double-blind randomised placebo-controlled trial
por: Walsh, Jennifer S., et al.
Publicado: (2019)

Efficacy and safety of faecal microbiota transplantation in patients with psoriatic arthritis: protocol for a 6-month, double-blind, randomised, placebo-controlled trial
por: Kragsnaes, Maja Skov, et al.
Publicado: (2018)

Paroxetine overdose
por: Gupta, Arun K., et al.
Publicado: (2005)

Comparison of Tolerance of Venlafaxine, Paroxetine and Amitriptyline in Depression Therapy
por: Miskovic, Mirjana
Publicado: (2015)

Amelioration of mild and moderate depression through Pranic Healing as adjuvant therapy: randomised double-blind controlled trial
por: Rajagopal, R, et al.
Publicado: (2017)

On-demand use of tramadol, sildenafil, paroxetine and local anaesthetics for the management of premature ejaculation: A randomised placebo-controlled clinical trial
por: Gameel, Tarek A., et al.
Publicado: (2013)

Protocol for a randomised, double-blind, placebo-controlled trial to explore the effect of tramadol in the prevention of postpartum depression (ETPPD)
por: Duan, Guangyou, et al.
Publicado: (2018)

Antidepressant and Neuroprotective Effects of 3-Hydroxy Paroxetine, an Analog of Paroxetine in Rats
por: Hernández-Arrambide, Pedro Efraín, et al.
Publicado: (2022)

Randomised, Double Blind, Placebo-Controlled Trial of Echinacea Supplementation in Air Travellers
por: Tiralongo, E., et al.
Publicado: (2012)

A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia
por: Shiina, Akihiro, et al.
Publicado: (2010)

Stopping smokeless tobacco with varenicline: randomised double blind placebo controlled trial
por: Fagerström, Karl, et al.
Publicado: (2010)

Randomised, Double-Blind, Placebo-Controlled Study of Iguratimod in the Treatment of Active Spondyloarthritis
por: Li, Yan, et al.
Publicado: (2021)

Paroxetine treatment in an animal model of depression improves sperm quality
por: Aghajani, Reyhane, et al.
Publicado: (2022)

Paroxetine-induced galactorrhea
por: Gulati, Prannay, et al.
Publicado: (2014)

Paroxetine-induced galactorrhea
por: Petrykiv, S., et al.
Publicado: (2022)

Treatment with sumatriptan 50 mg in the mild phase of migraine attacks in patients with infrequent attacks: a randomised, double-blind, placebo-controlled study
por: Tfelt-Hansen, P., et al.
Publicado: (2006)

Magnitude of placebo response in clinical trials of paroxetine for vasomotor symptoms: a meta-analysis
por: Rhodes, Joshua R., et al.
Publicado: (2023)

Comparison Between Tadalafil Plus Paroxetine and Paroxetine Alone in the Treatment of Premature Ejaculation
por: Moudi, Emadouddin, et al.
Publicado: (2016)

Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double blind trial
por: Dubée, Vincent, et al.
Publicado: (2021)

Protocol and Rationale-The Efficacy of Minocycline as an Adjunctive Treatment for Major Depressive Disorder: A Double Blind, Randomised, Placebo Controlled Trial
por: Dean, Olivia May, et al.
Publicado: (2014)

Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial
por: von Rotz, Robin, et al.
Publicado: (2022)

Adjunctive aripiprazole in risperidone-induced hyperprolactinaemia: double-blind, randomised, placebo-controlled trial
por: Raghuthaman, G., et al.
Publicado: (2015)

Randomised, double-blind, placebo-controlled pilot trial of omeprazole in idiopathic pulmonary fibrosis
por: Dutta, Prosenjit, et al.
Publicado: (2019)

Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial
por: Mullen, Michael, et al.
Publicado: (2019)

Palmitoylethanolamide for sleep disturbance. A double-blind, randomised, placebo-controlled interventional study
por: Rao, Amanda, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2sp04kkr6fs3n2e8q37p3dhjqd